AMNEAL PHARMACEUTICALS, INC. Income Taxes Paid
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Income Taxes Paid of $314.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-06-30 was -$2.14M.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $2.45M.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $3.75M, a 39.15% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $30.14M.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2025 was $21.33M, a 40.12% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2024 was $15.22M, a 509.78% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2023 was $2.50M, a 80.27% decline from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2022 was $12.65M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 6 month as first filed | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 9 month as first filed | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $314.00K 10-Q · filed 2026-08-06 | $4.07M derived: sum of 3 quarters · filed 2026-08-06 | $34.21M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-07 | $6.20M derived: sum of 2 quarters · filed 2026-05-07 | $36.34M derived: sum of 3 quarters · filed 2026-05-07 | $27.39M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $33.89M derived: sum of 2 quarters · filed 2026-02-27 | $24.94M derived: sum of 3 quarters · filed 2026-08-06 | $21.33M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $30.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $21.19M derived: sum of 2 quarters · filed 2026-08-06 | $17.58M 10-Q · filed 2025-11-06 | $23.74M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$12.56M 10-Q · filed 2026-08-06 | $12.56M 10-Q · filed 2025-08-07 | -$6.40M derived: sum of 3 quarters · filed 2026-08-06 | -$7.55M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$3.61M 10-Q · filed 2026-05-07 | $3.61M 10-Q · filed 2025-05-07 | $2.55M derived: sum of 2 quarters · filed 2026-05-07 | $1.40M derived: sum of 3 quarters · filed 2026-05-07 | $7.04M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.01M derived: sum of 2 quarters · filed 2026-02-27 | $10.65M derived: sum of 3 quarters · filed 2026-02-27 | $15.22M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | -$1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.49M derived: sum of 2 quarters · filed 2025-11-06 | $9.06M 10-Q · filed 2025-11-06 | $11.13M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $5.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.21M 10-Q · filed 2025-08-07 | $12.28M derived: sum of 3 quarters · filed 2026-02-27 | $8.79M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $4.57M 10-Q · filed 2025-05-07 | -$4.57M 10-Q · filed 2024-05-08 | $6.64M derived: sum of 2 quarters · filed 2026-02-27 | $3.15M derived: sum of 3 quarters · filed 2026-02-27 | $3.64M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.42M derived: sum of 2 quarters · filed 2026-02-27 | -$925.00K derived: sum of 3 quarters · filed 2026-02-27 | $2.50M 10-K · filed 2026-02-27 | -$2.50M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.00M derived: sum of 2 quarters · filed 2024-11-12 | $426.00K 10-Q · filed 2024-11-12 | $23.02M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.92M 10-Q · filed 2024-08-09 | $26.51M derived: sum of 3 quarters · filed 2025-02-28 | $23.31M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $3.42M 10-Q · filed 2024-05-08 | $26.01M derived: sum of 2 quarters · filed 2025-02-28 | $22.82M derived: sum of 3 quarters · filed 2025-02-28 | $20.46M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $22.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $19.40M derived: sum of 2 quarters · filed 2025-02-28 | $17.04M derived: sum of 3 quarters · filed 2025-02-28 | $12.65M 10-K · filed 2025-02-28 | -$12.65M 10-K · filed 2023-03-03 | |||
| 2022-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.55M derived: sum of 2 quarters · filed 2023-11-09 | -$9.94M 10-Q · filed 2023-11-09 | $9.94M 10-Q · filed 2022-11-07 | -$37.08M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | -$2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$6.75M 10-Q · filed 2023-08-08 | -$33.89M derived: sum of 3 quarters · filed 2024-03-14 | -$26.91M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | -$4.39M 10-Q · filed 2023-05-09 | $4.39M 10-Q · filed 2022-05-06 | -$31.53M derived: sum of 2 quarters · filed 2024-03-14 | -$24.55M derived: sum of 3 quarters · filed 2024-03-14 | -$20.68M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | -$27.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$20.17M derived: sum of 2 quarters · filed 2024-03-14 | -$16.29M derived: sum of 3 quarters · filed 2024-03-14 | -$15.56M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $10.85M derived: sum of 2 quarters · filed 2022-11-07 | $11.58M 10-Q · filed 2022-11-07 | -$11.58M 10-Q · filed 2021-11-08 | $2.28M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-06-30 | $3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.61M 10-Q · filed 2022-08-08 | -$4.69M derived: sum of 3 quarters · filed 2023-03-03 | $100.23M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $733.00K 10-Q · filed 2022-05-06 | -$8.57M derived: sum of 2 quarters · filed 2023-03-03 | $96.36M derived: sum of 3 quarters · filed 2023-03-03 | $97.44M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | -$9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $95.62M derived: sum of 2 quarters · filed 2023-03-03 | $96.71M derived: sum of 3 quarters · filed 2023-03-03 | $100.14M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $104.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $106.01M derived: sum of 2 quarters · filed 2021-11-08 | $109.44M 10-Q · filed 2021-11-08 | $107.84M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.52M 10-Q · filed 2021-08-09 | -$4.52M 10-Q · filed 2020-08-06 | $2.92M derived: sum of 3 quarters · filed 2022-03-01 | $6.24M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $3.43M 10-Q · filed 2021-05-07 | -$3.43M 10-Q · filed 2020-05-11 | $1.83M derived: sum of 2 quarters · filed 2022-03-01 | $5.15M derived: sum of 3 quarters · filed 2022-03-01 | $3.97M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.72M derived: sum of 2 quarters · filed 2022-03-01 | $542.00K derived: sum of 3 quarters · filed 2022-03-01 | $10.26M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.14M derived: sum of 2 quarters · filed 2020-11-06 | $11.86M 10-Q · filed 2020-11-06 | $52.19M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.53M 10-Q · filed 2020-08-06 | $48.86M derived: sum of 3 quarters · filed 2021-03-01 | $43.48M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $9.71M 10-Q · filed 2020-05-11 | $50.04M derived: sum of 2 quarters · filed 2021-03-01 | $44.66M derived: sum of 3 quarters · filed 2021-03-01 | $46.17M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $40.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $34.95M derived: sum of 2 quarters · filed 2021-03-01 | $36.46M derived: sum of 3 quarters · filed 2021-03-01 | $34.95M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$3.87M derived: sum of 2 quarters · filed 2019-11-07 | -$5.38M 10-Q · filed 2019-11-07 | $5.38M 10-Q · filed 2018-11-07 | -$15.18M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | -$9.80M derived: sum of 3 quarters · filed 2020-03-02 | -$5.78M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$1.51M 10-Q · filed 2019-05-09 | -$11.31M derived: sum of 2 quarters · filed 2020-03-02 | -$7.29M derived: sum of 3 quarters · filed 2020-03-02 | |||||
| 2017-12-31 | -$9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$5.78M derived: sum of 2 quarters · filed 2020-03-02 | -$5.78M 10-K · filed 2020-03-02 | $5.78M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $4.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $4.02M 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | |||||||
| 2016-12-31 | $4.92M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |